Previous 10 | Next 10 |
Active Penny Stocks To Watch This Week No matter how you feel about penny stocks or the stock market today, the fact is there’s money being made. While some equity classes may be riskier than others, if you can handle a little bit of that risk, the rewards can be great. One of the big...
-Newly-issued patent provides U.S. patent protection for ANNOVERA ® into 2039- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the United States Patent and Trademark Office (USPTO) has issued a patent that covers the labe...
Executive Management to Host Conference Call on May 6, 2020 at 8:30 a.m. ET TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its first quarter 2020 financial results on Wednesday, May 6, 2020, before the opening of ...
TherapeuticsMD Provides Business Updates, Suspends Guidance Due to COVID 19 TherapeuticsMD ( TXMD ) announced important updates about its business operations including introducing cost reduction initiatives. The company also stated that it has decided to suspend its guidance for FY 2020....
Arlington Asset Investment (NYSE: AI ) -21% after suspending Q1 dividend. More news on: Arlington Asset Investment Corp., BGC Partners, Inc., Altimmune, Inc., Stocks on the move, , Read more ...
TherapeuticsMD (NASDAQ: TXMD ) announces cost-reduction initiatives amid the uncertainties of the COVID-19 pandemic. It has also "suspended" its 2020 guidance. More news on: TherapeuticsMD, Inc., Healthcare stocks news, Read more ...
- Strong preliminary first quarter 2020 total net revenue projected to be more than $11 million – - vitaCare Prescription Services model allowing the Company to connect with more than 80% of patients - - Implementing staged contingency plan that can be adjusted as COVID-19 situa...
– Paul Bisaro and Gail Naughton, Ph.D., Appointed as Independent Directors – On behalf of the Board of Directors of TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, Chairman Tommy G. Thompson today announced the appointments of ...
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today provided an update on its business operations as the COVID-19 situation evolves. At this time, TherapeuticsMD continues to provide an uninterrupted supply of its portfolio of products for patients. The...
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate in the Cowen 40 th Annual Healthcare Conference in Boston. Chief Executive Officer Robert G. Finizio will provide an overview of the company at the conferen...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...